BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.

The Tissue Engineering and Regenerative Medicine International Society – Americas (TERMIS-AM) 2026 Conference brings together leading researchers, clinicians, industry innovators, and technology developers to explore the latest advances in tissue engineering, regenerative medicine, and advanced therapies.
Celebrating the 20th anniversary of TERMIS, the 2026 conference will focus on the theme “Bench. Chip. Clinic. Where Y’at in Regeneration?” and highlight emerging technologies that are accelerating the translation of scientific discoveries into clinical applications. Featured topics include CRISPR and lipid nanoparticles, organ-on-chip models, artificial intelligence, biomaterials, cell therapies, and regenerative medicine innovations.
ARMI plans to participate in TERMIS-AM 2026 to engage with the global regenerative medicine community, strengthen collaborations, and explore scientific and manufacturing advances that support the development, scale-up, and deployment of next-generation therapies. The conference provides a valuable opportunity to connect research, technology development, manufacturing, and clinical translation across the regenerative medicine landscape.
Join leaders from academia, industry, healthcare, and government in New Orleans for four days of scientific discovery, networking, and collaboration focused on advancing the future of regenerative medicine.